|
Volumn 97, Issue 1, 2006, Pages 44-47
|
Effects of morning versus evening intake of atorvastatin on major cardiac event and restenosis rates in patients undergoing first elective percutaneous coronary intervention
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTILIPEMIC AGENT;
ATORVASTATIN;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
C REACTIVE PROTEIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ADULT;
AGED;
ANGIOCARDIOGRAPHY;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
DRUG EFFECT;
FEMALE;
HEART DEATH;
HEART DISEASE;
HEART INFARCTION;
HUMAN;
LIPID BLOOD LEVEL;
MAJOR CLINICAL STUDY;
MALE;
PERCUTANEOUS CORONARY INTERVENTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RESTENOSIS;
UNSTABLE ANGINA PECTORIS;
AGED;
ANGINA PECTORIS;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
C-REACTIVE PROTEIN;
CHRONOTHERAPY;
CORONARY RESTENOSIS;
CORONARY STENOSIS;
FEMALE;
HEPTANOIC ACIDS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LIPIDS;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
PROSPECTIVE STUDIES;
PYRROLES;
TREATMENT OUTCOME;
|
EID: 29244455261
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/j.amjcard.2005.07.107 Document Type: Article |
Times cited : (13)
|
References (6)
|